ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
64 hedge funds and large institutions have $61.9M invested in Adamas Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+1
Holders Change %
+1.59%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
21
Reduced
17
Closed
9
Calls
$61K
Puts
$111K
Net Calls
-$50K
Net Calls Change
-$191K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$4.79M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.54M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$796K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$3.5M |
| 5 |
JGC
J. Goldman & Co
New York
|
$422K |
